Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000513450 | SCV000608525 | likely pathogenic | not provided | 2017-03-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000513450 | SCV000705703 | pathogenic | not provided | 2017-02-09 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000672338 | SCV000797435 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-01-25 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001073947 | SCV001239512 | likely pathogenic | Retinal dystrophy | 2018-07-27 | criteria provided, single submitter | clinical testing | |
Department of Otolaryngology – Head & Neck Surgery, |
RCV001375184 | SCV001571790 | likely pathogenic | Hearing impairment | 2021-04-12 | criteria provided, single submitter | clinical testing | PVS1_Strong, PM2_Moderate |
Labcorp Genetics |
RCV000513450 | SCV002232768 | pathogenic | not provided | 2023-02-03 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 444203). This premature translational stop signal has been observed in individual(s) with clinical features of USH2A-related conditions (PMID: 32037395). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp1706*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |
Genome- |
RCV003449461 | SCV004181843 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449460 | SCV004181844 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003449461 | SCV004200697 | pathogenic | Retinitis pigmentosa 39 | 2023-05-30 | criteria provided, single submitter | clinical testing |